×
Hero Background

Polysomnography Devices Companies

ID: MRFR/HC/10221-HCR
128 Pages
Rahul Gotadki
October 2025

Polysomnography (PSG) is a diagnostic test used in sleep medicine to study sleep patterns and diagnose sleep disorders. Various companies specialize in the manufacturing and development of polysomnography devices.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the Polysomnography Devices Market

Polysomnography Devices Market

 


Latest Polysomnography Devices Companies Updates:


Philips (Netherlands): Launched its Somnolyzer 24G device in October 2023, featuring advanced sleep staging algorithms and improved sensor technology for comprehensive sleep analysis at home or in ambulatory settings.


Emfit (US): Secured FDA clearance for its Quell® wearable for treating chronic insomnia in December 2023, expanding its portfolio of non-invasive sleep therapy solutions.


Cadwell Laboratories, Inc. (US): Announced a strategic partnership with Neurobit (Israel) in September 2023 to develop and integrate AI-powered sleep staging algorithms into existing PSG devices, enhancing diagnostic capabilities.


Nox Medical (US): Received FDA approval for its Nox A1+ Home Sleep Testing System in July 2023, offering a compact and user-friendly option for home-based sleep apnea diagnosis.


Brainlab (Germany): Showcased its new Quantinuum sleep EEG System at a recent medical conference, highlighting its potential for advanced sleep monitoring and research applications.


List of Polysomnography Devices Key companies in the market:



  • CleveMed

  • Nox Medical

  • SOMNOmedics GmbH

  • ResMed

  • Cidelec

  • Vyaire Medical

  • Koninklijke Philips

  • Natus Medical

  • BMC Medical

  • Recorders & Medicare Systems

  • CleveMed

  • Medicom MTD